欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号AT/H/1374/001
药品名称Beclometasone formoterol Genetic 100/6 micrograms per actuation
活性成分
    • Beclometasone dipropionate 100.0 µg
    • Formoterolfumarat dihydrate 6.0 µg
剂型Pressurised inhalation, solution
上市许可持有人Genetic S.p.A. Via G. Della Monica 26 84083 Salerno Italy
参考成员国 - 产品名称Austria (AT)
互认成员国 - 产品名称
    • Malta (MT)
      Beclometasone formoterol Genetic 100 microgram/6 microgram per actuation pressurized inhalation solution
    • Poland (PL)
    • Croatia (HR)
    • Latvia (LV)
    • Germany (DE)
      Beclometason/Formoterol Genetic 100 Mikrogramm/6 Mikrogramm pro Inhalation Druckgasinhalation, Lösung
    • Lithuania (LT)
      -
    • Belgium (BE)
    • Estonia (EE)
    • Netherlands (NL)
    • Hungary (HU)
    • Luxembourg (LU)
    • Bulgaria (BG)
      Beclomethasone formoterol Generic
    • Ireland (IE)
    • Cyprus (CY)
      Beclometasone formoterol Genetic 100 microgram/6 microgram per actuation pressurized inhalation solution
    • France (FR)
    • Czechia (CZ)
      beclometasoni formoteroli Genetic 100 mikrogramů/6 mikrogramů/dávka roztok k inhalaci v tlakovém obalu
    • Spain (ES)
    • Romania (RO)
    • Portugal (PT)
    • Slovakia (SK)
    • Italy (IT)
    • Slovenia (SI)
    • Greece (GR)
许可日期2024/10/23
最近更新日期2024/10/23
药物ATC编码
    • R03AK08 formoterol and beclometasone
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase